COL/344
WTO/SPS
CO Kolumbien
  • 65 - Landwirtschaft
2023-05-27
2023-04-04

Live birds, as well as fertile or embryonated eggs, eggs for consumption, fresh meat and meat products, other products of avian origin.

RESOLUCIÓN No. 00002478 del 17 de marzo de 2023, "Por la cual se establecen medidas sanitarias temporales por la presencia de Influenza Aviar de Alta Patogenicidad (IAAP)" (Resolution No. 00002478 of 17 March 2023, establishing temporary sanitary measures owing to the presence of highly pathogenic avian influenza (HPAI)) Language(s): Spanish. Number of pages: 4

The notified Resolution No. 00002478 of 17 March 2023, establishing temporary sanitary measures owing to the presence of highly pathogenic avian influenza (HPAI)),

PROHIBITS the entry into Colombia of at-risk birds and products that are capable of transmitting avian influenza from countries that have reported the presence of HPAI in poultry (commercial poultry farms), until their health situation is under control and their health status with WOAH is restored to that of a disease-free country.

PARAGRAPH. The Colombian Agricultural Institute (ICA), during the time period provided for in this article, shall assess the risk of the disease being introduced into Colombia by means of a review of updated official information from countries with reports of the presence of highly pathogenic avian influenza, on the status of the disease or in situ verification by the Institute's officials and/or staff.

SUSPENSION OF APPLICATIONS. Applications submitted to the ICA for the import of at-risk birds and products capable of transmitting avian influenza from any country that has notified the presence of highly pathogenic avian influenza (HPAI) in commercial birds shall be suspended for the time period provided for in Article 1 of the notified Resolution.

PARAGRAPH. The Colombian Agricultural Institute (ICA), during the time period provided for in this article, may assess import applications for live birds and/or avian material posing a health risk from countries with reports of the presence of highly pathogenic avian influenza in commercial birds, if such applications originate from a disease-free compartment or zone, such a risk assessment does not imply approval by the Institute.